212 related articles for article (PubMed ID: 34294193)
1. Serum Antibodies to N-Glycolylneuraminic Acid Are Elevated in Duchenne Muscular Dystrophy and Correlate with Increased Disease Pathology in Cmah
Martin PT; Kawanishi K; Ashbrook A; Golden B; Samraj A; Crowe KE; Zygmunt DA; Okerblom J; Yu H; Maki A; Diaz S; Chen X; Janssen PML; Varki A
Am J Pathol; 2021 Aug; 191(8):1474-1486. PubMed ID: 34294193
[TBL] [Abstract][Full Text] [Related]
2. N-Glycolylneuraminic acid deficiency worsens cardiac and skeletal muscle pathophysiology in α-sarcoglycan-deficient mice.
Martin PT; Camboni M; Xu R; Golden B; Chandrasekharan K; Wang CM; Varki A; Janssen PM
Glycobiology; 2013 Jul; 23(7):833-43. PubMed ID: 23514716
[TBL] [Abstract][Full Text] [Related]
3. Polyclonal human antibodies against glycans bearing red meat-derived non-human sialic acid N-glycolylneuraminic acid are stable, reproducible, complex and vary between individuals: Total antibody levels are associated with colorectal cancer risk.
Samraj AN; Bertrand KA; Luben R; Khedri Z; Yu H; Nguyen D; Gregg CJ; Diaz SL; Sawyer S; Chen X; Eliassen H; Padler-Karavani V; Wu K; Khaw KT; Willett W; Varki A
PLoS One; 2018; 13(6):e0197464. PubMed ID: 29912879
[TBL] [Abstract][Full Text] [Related]
4. A human-specific deletion in mouse Cmah increases disease severity in the mdx model of Duchenne muscular dystrophy.
Chandrasekharan K; Yoon JH; Xu Y; deVries S; Camboni M; Janssen PM; Varki A; Martin PT
Sci Transl Med; 2010 Jul; 2(42):42ra54. PubMed ID: 20668298
[TBL] [Abstract][Full Text] [Related]
5. Human species-specific loss of CMP-
Kawanishi K; Dhar C; Do R; Varki N; Gordts PLSM; Varki A
Proc Natl Acad Sci U S A; 2019 Aug; 116(32):16036-16045. PubMed ID: 31332008
[TBL] [Abstract][Full Text] [Related]
6. Dietary Neu5Ac Intervention Protects Against Atherosclerosis Associated With Human-Like Neu5Gc Loss-Brief Report.
Kawanishi K; Coker JK; Grunddal KV; Dhar C; Hsiao J; Zengler K; Varki N; Varki A; Gordts PLSM
Arterioscler Thromb Vasc Biol; 2021 Nov; 41(11):2730-2739. PubMed ID: 34587757
[TBL] [Abstract][Full Text] [Related]
7. A comparative study of N-glycolylneuraminic acid (Neu5Gc) and cytotoxic T cell (CT) carbohydrate expression in normal and dystrophin-deficient dog and human skeletal muscle.
Martin PT; Golden B; Okerblom J; Camboni M; Chandrasekharan K; Xu R; Varki A; Flanigan KM; Kornegay JN
PLoS One; 2014; 9(2):e88226. PubMed ID: 24505439
[TBL] [Abstract][Full Text] [Related]
8. Biochemical, Cellular, Physiological, and Pathological Consequences of Human Loss of N-Glycolylneuraminic Acid.
Okerblom J; Varki A
Chembiochem; 2017 Jul; 18(13):1155-1171. PubMed ID: 28423240
[TBL] [Abstract][Full Text] [Related]
9. Profiling Anti-Neu5Gc IgG in Human Sera with a Sialoglycan Microarray Assay.
Leviatan Ben-Arye S; Yu H; Chen X; Padler-Karavani V
J Vis Exp; 2017 Jul; (125):. PubMed ID: 28745644
[TBL] [Abstract][Full Text] [Related]
10.
Perota A; Galli C
Front Immunol; 2019; 10():2396. PubMed ID: 31681287
[TBL] [Abstract][Full Text] [Related]
11. Novel mechanism for the generation of human xeno-autoantibodies against the nonhuman sialic acid N-glycolylneuraminic acid.
Taylor RE; Gregg CJ; Padler-Karavani V; Ghaderi D; Yu H; Huang S; Sorensen RU; Chen X; Inostroza J; Nizet V; Varki A
J Exp Med; 2010 Aug; 207(8):1637-46. PubMed ID: 20624889
[TBL] [Abstract][Full Text] [Related]
12. Increased plasma lipid levels exacerbate muscle pathology in the mdx mouse model of Duchenne muscular dystrophy.
Milad N; White Z; Tehrani AY; Sellers S; Rossi FMV; Bernatchez P
Skelet Muscle; 2017 Sep; 7(1):19. PubMed ID: 28899419
[TBL] [Abstract][Full Text] [Related]
13. Involvement of a non-human sialic Acid in human cancer.
Samraj AN; Läubli H; Varki N; Varki A
Front Oncol; 2014; 4():33. PubMed ID: 24600589
[TBL] [Abstract][Full Text] [Related]
14. A comparison of the bone and growth phenotype of
Wood CL; Suchacki KJ; van 't Hof R; Cawthorn WP; Dillon S; Straub V; Wong SC; Ahmed SF; Farquharson C
Dis Model Mech; 2020 Jan; 13(2):. PubMed ID: 31754018
[TBL] [Abstract][Full Text] [Related]
15. N-glycolylneuraminic acid on human epithelial cells prevents entry of influenza A viruses that possess N-glycolylneuraminic acid binding ability.
Takahashi T; Takano M; Kurebayashi Y; Masuda M; Kawagishi S; Takaguchi M; Yamanaka T; Minami A; Otsubo T; Ikeda K; Suzuki T
J Virol; 2014 Aug; 88(15):8445-56. PubMed ID: 24829344
[TBL] [Abstract][Full Text] [Related]
16. A simple method for assessment of human anti-Neu5Gc antibodies applied to Kawasaki disease.
Padler-Karavani V; Tremoulet AH; Yu H; Chen X; Burns JC; Varki A
PLoS One; 2013; 8(3):e58443. PubMed ID: 23520510
[TBL] [Abstract][Full Text] [Related]
17. Phylogenetic Distribution of CMP-Neu5Ac Hydroxylase (CMAH), the Enzyme Synthetizing the Proinflammatory Human Xenoantigen Neu5Gc.
Peri S; Kulkarni A; Feyertag F; Berninsone PM; Alvarez-Ponce D
Genome Biol Evol; 2018 Jan; 10(1):207-219. PubMed ID: 29206915
[TBL] [Abstract][Full Text] [Related]
18. Evidence for a human-specific mechanism for diet and antibody-mediated inflammation in carcinoma progression.
Hedlund M; Padler-Karavani V; Varki NM; Varki A
Proc Natl Acad Sci U S A; 2008 Dec; 105(48):18936-41. PubMed ID: 19017806
[TBL] [Abstract][Full Text] [Related]
19. Production and Purification of Secretory Simian Cytidine Monophosphate-N-acetylneuraminic Acid Hydroxylase Using Baculovirus-Protein Expression System.
Takahashi T; Kawagishi S; Funahashi H; Hayashi N; Suzuki T
Biol Pharm Bull; 2015; 38(8):1220-6. PubMed ID: 26235586
[TBL] [Abstract][Full Text] [Related]
20. Metabolism of vertebrate amino sugars with N-glycolyl groups: mechanisms underlying gastrointestinal incorporation of the non-human sialic acid xeno-autoantigen N-glycolylneuraminic acid.
Banda K; Gregg CJ; Chow R; Varki NM; Varki A
J Biol Chem; 2012 Aug; 287(34):28852-64. PubMed ID: 22692204
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
